Monday, September 14, 2026

Yonsei Researchers Discover Experimental Compound That Targets Drug-Resistant Metastatic Cancer Cells

A research team at Yonsei University has discovered a substance to treat resistant metastatic cancer.

UN AI Hub: South Korea’s Ambitious Bid to Become a Global AI Collaboration Leader

Prime Minister Kim Min-seok aims to host a UN AI Hub in Korea, enhancing global AI cooperation and addressing international challenges.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Tag: D&D Pharmatech

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us